Gadia, Viviano S.

HRN: 23-28-21  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/03/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
07/03/2023
07/09/2023
IV
2.25g
Q6
Sepsis Multifactorial: CAP-HR, Sacral Ulcer
Waiting Final Action 

Indication:  Empiric    Type of Infection:  PneumoniaSkin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: No  Wrong Dose  Wrong Dose

Overall appropriateness: No  Wrong Dose

Intervention



Type of Intervention done:

                    

           


Acceptance: